We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+8.39%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$11.3B
AUM Growth
+$1.62B
Cap. Flow
+$896M
Cap. Flow %
7.96%
Top 10 Hldgs %
56.76%
Holding
110
New
30
Increased
24
Reduced
18
Closed
25

Top Buys

Rank Stock Value
1
EFX icon
Equifax
EFX
+$171M
2
TWX
Time Warner Inc
TWX
+$146M
3
NXPI icon
NXP Semiconductors
NXPI
+$145M
4
KITE
Kite Pharma, Inc.
KITE
+$136M
5
TRU icon
TransUnion
TRU
+$106M

Top Sells

Rank Stock Value
1
MBLY
Mobileye N.V.
MBLY
+$371M
2
SBAC icon
SBA Communications
SBAC
+$132M
3
TMH
Team Health Holdings Inc
TMH
+$105M
4
ALR
Alere Inc
ALR
+$82.4M
5
META icon
Meta Platforms (Facebook)
META
+$75.8M

Sector Composition

Rank Sector Weight
1 Technology 23.58%
2 Healthcare 20.65%
3 Communication Services 20.02%
4 Industrials 7.53%
5 Financials 3.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRU icon
26
TransUnion
TRU
$16.2B
$110M 0.98%
+2,322,158
New +$106M
AZN icon
27
AstraZeneca
AZN
$257B
$108M 0.96%
1,590,000
+1,302,500
+453% +$82.3M
BUD icon
28
AB InBev
BUD
$155B
$107M 0.95%
+900,000
New +$105M
LBTYA icon
29
Liberty Global Class A
LBTYA
$3.63B
$101M 0.9%
2,992,935
-1,227,169
-29% -$40.9M
LBTYK icon
30
Liberty Global Class C
LBTYK
$3.55B
$101M 0.9%
3,089,773
-1,263,163
-29% -$40.8M
HUN icon
31
Huntsman Corp
HUN
$1.75B
$96M 0.85%
3,500,000
-1,920,000
-35% -$51.2M
CPN
32
DELISTED
Calpine Corporation
CPN
$95.3M 0.85%
+6,460,000
New +$92.2M
BMY icon
33
Bristol-Myers Squibb
BMY
$137B
$86.4M 0.77%
+1,355,000
New +$79.1M
HLF icon
34
Herbalife
HLF
$1.33B
$85.5M 0.76%
2,519,670
-1,678,736
-40% -$57.5M
FOLD
35
DELISTED
Amicus Therapeutics
FOLD
$76.6M 0.68%
5,081,055
+2,081,055
+69% +$27.5M
GILD icon
36
Gilead Sciences
GILD
$181B
$76.6M 0.68%
+945,000
New +$72.3M
AKRX
37
DELISTED
Akorn Inc
AKRX
$75.7M 0.67%
+2,280,000
New +$75.7M
CHTR icon
38
Charter Communications
CHTR
$17.9B
$69.5M 0.62%
191,255
-143,570
-43% -$53.4M
GNCMA
39
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
$67.1M 0.6%
1,643,800
+1,004,824
+157% +$41M
CMCSA icon
40
Comcast
CMCSA
$95.3B
$67M 0.6%
1,741,621
-1,607,565
-48% -$63.3M
BRCD
41
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$61.3M 0.54%
+5,130,000
New +$63.4M
KYNB
42
Kyntra Bio
KYNB
$30.4M
$59.2M 0.53%
44,000
+1,120
+3% +$1.18M
ABBV icon
43
AbbVie
ABBV
$468B
$52M 0.46%
585,000
-250,000
-30% -$19M
ELV icon
44
Elevance Health
ELV
$86.9B
$39.9M 0.35%
210,000
– –
RC
45
Ready Capital
RC
$311M
$36.5M 0.32%
2,324,236
– –
XLRN
46
DELISTED
Acceleron Pharma
XLRN
$35.9M 0.32%
+963,000
New +$33.4M
GRFS
47
Grifois
GRFS
$5.44B
$31.3M 0.28%
1,429,773
+349,899
+32% +$7.26M
ESV
48
DELISTED
Ensco Rowan plc
ESV
$29.4M 0.26%
+1,230,000
New +$24.5M
EXEL icon
49
Exelixis
EXEL
$13.4B
$28.8M 0.26%
1,190,000
-325,000
-21% -$8.65M
LKFT
50
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.89B
$24M 0.21%
+236,216
New +$20.6M
1
2
3 4 5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q3 2017 Portfolio in Review

As of Q3 2017, Thomas Steyer held 110 positions worth $11.3B, up 17% from $9.63B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Thomas Steyer deployed $896M of net new capital in Q3 2017, opening 30 new positions and adding to 24 existing holdings. Its largest new stake was Equifax: 1,290,000 shares worth $137M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was SBA Communications, an estimated $132M trimmed.

  • Thomas Steyer's largest Q3 2017 buy was Equifax: 1,290,000 shares worth $137M.
  • Thomas Steyer added most to Time Warner Inc in Q3 2017, an estimated $146M increase.
  • Thomas Steyer's biggest Q3 2017 reduction was SBA Communications, cutting an estimated $132M.
  • Thomas Steyer fully exited Mobileye N.V. in Q3 2017, selling an estimated $371M.
  • Thomas Steyer's ten largest holdings make up 57% of its $11.3B portfolio in Q3 2017.
  • Thomas Steyer opened 30 new positions and closed 25 in Q3 2017.
  • Thomas Steyer's portfolio value rose 17% quarter-over-quarter to $11.3B.

Based on Farallon Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.